Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 3 1Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Osteoporosis 1Lung Neoplasms 1Endometrial Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Linseed Oil × Clear all
NCT02475330 2021-06-08

Dietary Flaxseed in NSCLC

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
33 enrolled
Thoracic

Lung Neoplasms

NCT00049309 2017-02-23

Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer

Duke University

Phase 2 Completed
161 enrolled
Genitourinary

Prostatic Neoplasms

NCT00693082 2012-11-20

Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation

Duke University

Phase 2 Terminated
4 enrolled

Polycystic Ovary Syndrome

NCT00010829 2006-08-18

Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors

National Center for Complementary and Integrative Health (NCCIH)

Phase 2 Completed
BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Osteoporosis, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡